<SEC-DOCUMENT>0001178879-20-000017.txt : 20200323
<SEC-HEADER>0001178879-20-000017.hdr.sgml : 20200323
<ACCEPTANCE-DATETIME>20200323070107
ACCESSION NUMBER:		0001178879-20-000017
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20200323
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200323
DATE AS OF CHANGE:		20200323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AMICUS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001178879
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				200422823
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33497
		FILM NUMBER:		20733536

	BUSINESS ADDRESS:	
		STREET 1:		1 CEDAR BROOK DRIVE
		CITY:			CRANBURY
		STATE:			NJ
		ZIP:			08512
		BUSINESS PHONE:		(609) 662-2000

	MAIL ADDRESS:	
		STREET 1:		1 CEDAR BROOK DRIVE
		CITY:			CRANBURY
		STATE:			NJ
		ZIP:			08512

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMICUS THERAPEUTICS INC
		DATE OF NAME CHANGE:	20020729
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>fold-20200323.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:16009264-c148-47e0-ba43-b96e1478488b,g:8a3733b3-3c4d-4fad-9c12-2a373ff36d7c,d:ec1065b79e4545139441e5ddfd0f68d0--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>fold-20200323</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF80L2ZyYWc6OWM1YzQwOGI0Y2ViNDA5ODhkODgxMTdmMzZlYzVjYWIvdGFibGU6NmRlMmFlNzFlNGJjNGZjZjk3YmYzZDY4ZjYwMTExODUvdGFibGVyYW5nZTo2ZGUyYWU3MWU0YmM0ZmNmOTdiZjNkNjhmNjAxMTE4NV8xLTEtMS0xLTA_e55cb187-f279-4102-97b4-2efc8f94f429">0001178879</ix:nonNumeric><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF80L2ZyYWc6OWM1YzQwOGI0Y2ViNDA5ODhkODgxMTdmMzZlYzVjYWIvdGFibGU6NmRlMmFlNzFlNGJjNGZjZjk3YmYzZDY4ZjYwMTExODUvdGFibGVyYW5nZTo2ZGUyYWU3MWU0YmM0ZmNmOTdiZjNkNjhmNjAxMTE4NV8yLTEtMS0xLTA_d652aa0f-5db7-4843-b366-51e0d2b0301f">false</ix:nonNumeric><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF80L2ZyYWc6OWM1YzQwOGI0Y2ViNDA5ODhkODgxMTdmMzZlYzVjYWIvdGFibGU6NmRlMmFlNzFlNGJjNGZjZjk3YmYzZDY4ZjYwMTExODUvdGFibGVyYW5nZTo2ZGUyYWU3MWU0YmM0ZmNmOTdiZjNkNjhmNjAxMTE4NV8zLTEtMS0xLTA_c3483061-77d2-4b83-8aaf-daf0271d6071">&#9744;</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="fold-20200323.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001178879</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-02</xbrli:startDate><xbrli:endDate>2020-03-02</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="iec1065b79e4545139441e5ddfd0f68d0_1"></div><div style="height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:18pt;padding-left:27pt;text-align:center;margin-bottom:0.15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">UNITED STATES</span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">WASHINGTON, D.C. 20549</span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;margin-top:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM0_35dc0c17-ab4f-433d-aeee-c0b3eae25ff8">8-K</ix:nonNumeric> </span></div><div style="padding-left:29.25pt;"><span><br/></span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">CURRENT REPORT PURSUANT TO</span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">SECTION 13 OR 15(d) OF THE</span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="padding-left:29.25pt;"><span><br/></span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date of Report (Date of earliest event reported): </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18yMjY_78812f4d-1233-4e55-9b86-6f514b0f5f81">March 23, 2020</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzQx_c7a6bba3-f5e1-4aaa-9cf0-c56d3dcef041">AMICUS THERAPEUTICS, INC.</ix:nonNumeric> </span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Exact Name of Registrant as Specified in Its Charter)</span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span><br/></span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM1_e7361dde-8b46-4841-8750-28db53db258a">Delaware</ix:nonNumeric> </span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(State or Other Jurisdiction of</span></div><div style="text-indent:2.25pt;padding-left:27pt;text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Incorporation)</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:32.078%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.777%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:29.983%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.777%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:29.985%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Delaware</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6OTQ2MjMzYWNiYTRkNDU5NjgxZTliYmRjOTUwOTI2OGYvdGFibGVyYW5nZTo5NDYyMzNhY2JhNGQ0NTk2ODFlOWJiZGM5NTA5MjY4Zl8wLTItMS0xLTA_d4fcaabc-606f-447a-b846-516b6366b692">001-33497</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6OTQ2MjMzYWNiYTRkNDU5NjgxZTliYmRjOTUwOTI2OGYvdGFibGVyYW5nZTo5NDYyMzNhY2JhNGQ0NTk2ODFlOWJiZGM5NTA5MjY4Zl8wLTQtMS0xLTA_5d9fb3e9-895a-4164-b10b-c6a8f8b6ba9f">71-0869350</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Commission<br/>File Number)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMw_f67dd951-542a-45ff-95ff-d5b75529db12">1 Cedar Brook Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzQy_99ef1f62-08c2-476e-95b6-02a4d77d4c94">Cranbury</ix:nonNumeric>, <ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM2_32b89240-65d4-489c-8d17-54c75bcdcbd5">NJ</ix:nonNumeric> <ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMx_5a9667c1-6556-42a0-af99-cc77e82d22d5">08512</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">(Address of Principal Executive Offices, and Zip Code)</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM3_abbc9281-0c14-4620-944b-0e77eab1160d">609</ix:nonNumeric>-<ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM4_033be30d-d574-470c-be85-2aaad502f94a">662-2000</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%;">Registrant&#8217;s Telephone Number, Including Area Code</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Former Name or Former Address, if Changed Since Last Report.)</span></div><div style="padding-left:29.25pt;"><span><br/></span></div><div style="text-indent:2.25pt;padding-left:29.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:-49.5pt;padding-left:49.5pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y183Nzc_c3483061-77d2-4b83-8aaf-daf0271d6071">&#9744;</ix:nonNumeric> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="text-indent:-49.5pt;padding-left:49.5pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM5_8d09c0c8-97d2-494d-834b-da9170d70d77">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="text-indent:-49.5pt;padding-left:49.5pt;margin-bottom:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMy_78b2155b-0052-4571-95a4-bd5345c71675">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="text-indent:-49.5pt;padding-left:49.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzQw_f784ed87-cade-4e99-8ceb-df5f2b52c31b">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="text-indent:-20.25pt;padding-left:49.5pt;"><span><br/></span></div><div style="text-indent:-49.5pt;padding-left:49.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:31.002%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:26.895%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:36.103%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol(s)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6YTZmZTRmZWM1ZThiNGQ5OWI4MGFmYzE2MzY1ODVhNzMvdGFibGVyYW5nZTphNmZlNGZlYzVlOGI0ZDk5YjgwYWZjMTYzNjU4NWE3M18xLTAtMS0xLTA_06baecc4-56f8-494d-8c14-b3a32a0a7b7b">Common Stock Par Value $0.01</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6YTZmZTRmZWM1ZThiNGQ5OWI4MGFmYzE2MzY1ODVhNzMvdGFibGVyYW5nZTphNmZlNGZlYzVlOGI0ZDk5YjgwYWZjMTYzNjU4NWE3M18xLTEtMS0xLTA_72d10484-e9c2-40be-90b5-2458138fdbd5">FOLD</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:1pt solid #000000;border-left:1pt solid #000000;padding-left:1pt;border-right:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6YTZmZTRmZWM1ZThiNGQ5OWI4MGFmYzE2MzY1ODVhNzMvdGFibGVyYW5nZTphNmZlNGZlYzVlOGI0ZDk5YjgwYWZjMTYzNjU4NWE3M18xLTItMS0xLTA_cafa2d9f-2edc-4956-827d-9268e50dd325">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).  Emerging growth company </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMz_3f21207b-0c8d-40e0-b8b4-17eb81daa9f8">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:right;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9744;</span></div><div><span><br/></span></div><div id="iec1065b79e4545139441e5ddfd0f68d0_7"></div><div style="text-indent:2.25pt;padding-left:29.25pt;"><span><br/></span></div><div style="text-indent:2.25pt;padding-left:29.25pt;"><span><br/></span></div><div style="text-indent:2.25pt;padding-left:29.25pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:2.25pt;padding-left:29.25pt;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 8.01 Other Events</span></div><div style="text-indent:2.25pt;padding-left:29.25pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;On March 23, 2020, Amicus Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release confirming business continuity and 2020 key strategic priorities in response to the novel coronavirus (Covid-19) pandemic and announced proactive efforts to support public health initiatives, patients and employees. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. </span></div><div><span><br/></span></div><div><span><br/></span></div><div style="padding-left:27pt;"><span><br/></span></div><div style="text-indent:2.25pt;padding-left:29.25pt;margin-bottom:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%;">Item 9.01 Financial Statements and Exhibits</span></div><div style="text-indent:2.25pt;padding-left:29.25pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%;">(d) Exhibits:</span></div><div style="text-indent:2.25pt;padding-left:29.25pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:87.280%;"><tr><td style="width:1.0%;"></td><td style="width:20.278%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:75.722%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exhibit No.</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Description</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex991org.htm">99.1</a></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;-sec-extract:exhibit;" href="ex991org.htm">Press release dated March 23, 2020</a></span></div></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">104&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="height:42.75pt;width:100%;"><div><span><br/></span></div></div><div id="iec1065b79e4545139441e5ddfd0f68d0_10"></div><div style="text-indent:18pt;padding-left:27pt;text-align:center;margin-bottom:0.15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:232%;text-decoration: underline;">Signature Page</span></div><div style="text-indent:18pt;padding-left:27pt;margin-bottom:0.15pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="text-indent:18pt;padding-left:27pt;margin-bottom:0.15pt;"><span><br/></span></div><div style="text-align:center;margin-bottom:6pt;"><table style="margin-left:auto;margin-right:auto;border-collapse:collapse;text-align:left;text-indent:0pt;display:inline-table;width:87.865%;"><tr><td style="width:1.0%;"></td><td style="width:45.420%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:50.580%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">AMICUS THERAPEUTICS, INC.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date: March 23, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">By:  /s/ Ellen S. Rosenberg</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name: Ellen S. Rosenberg</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title: Chief Legal Officer and Corporate Secretary</span></td></tr></table></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991org.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iba770c19800540beb22092cd8344acd7_1"></div><div style="height:72pt;width:100%;"><div><img alt="image01.jpg" src="image01.jpg" style="height:48px;width:142px;"></div></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">Amicus Therapeutics Confirms Business Continuity, 2020 Strategic Priorities and Announces Proactive Efforts to Support Public Health Initiatives, Patients &#38; Employees</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CRANBURY, NJ, March 23, 2020</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#8211; </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Amicus Therapeutics</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (Nasdaq&#58; FOLD), a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that the Company has proactively taken numerous measures in response to the novel coronavirus (COVID-19)  pandemic to support the rare disease community globally and to ensure the achievement of its 2020 key strategic priorities. In support of its patients, people, and programs, a COVID-19 internal Amicus task force chaired by Chairman &#38; CEO John F. Crowley was established in early March and meets regularly via video conference to assess COVID-19 developments and their impacts on company plans and strategies. </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Our Patients</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. Amicus is committed to providing uninterrupted access to medicines for those who are in need of a treatment.  </font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Global supply chains for Galafold</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> are robust and have not been interrupted. Amicus believes the Company will continue to be able to supply this oral precision medicine for any and all people living with Fabry disease who have an amenable variant. </font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The Company also has a high degree of confidence that participants enrolled in all clinical studies for AT-GAA for Pompe disease, including the Phase 3 PROPEL study, will continue to receive study drug and that this study will be completed on schedule.</font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The Company has taken steps to reinforce and elevate the resources provided to patient community partners, which is also detailed on our corporate </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">website</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. </font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Our People.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Amicus is aligned with public health strategies designed to prevent the spread of COVID-19 in order to protect our global workforce. </font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">In addition to instituting social distancing efforts, the Company mandated a work from home policy for all global Amicus offices as of March 12,</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2020. </font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Amicus is focused on ensuring the health and wellbeing of its global workforce and maintaining the safety of all our employees across the globe. The </font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Amicus Cares</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> internal initiative was launched last week to respond to the needs of employees during this unprecedented global health crisis. </font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Company executives and medical personnel are also advising and assisting with local, state and federal authorities in certain instances.</font></div><div style="padding-left:36pt;text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Our Programs.</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Amicus remains dedicated to delivering high-quality medicines for people living with rare diseases. Toward that end, Amicus has instituted a business continuity plan that it believes ensures the business will continue to perform and deliver on its mission for patients and shareholders. Based on current information, the Company continues to believe it will achieve its 2020 key strategic priorities, including&#58;</font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Achieve $250 million to $260 million of global product revenue for Galafold</font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Complete Pompe Phase 3 PROPEL study, enroll pediatric studies and advance manufacturing to support 2021 BLA and MAA of AT-GAA</font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Advance clinical development, manufacturing and regulatory discussions for CLN6 and CLN3 Batten programs</font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Progress Pompe gene therapy towards IND and disclose up to two additional IND candidates</font></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Maintain strong financial position</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As a leader in the global rare-disease community, our top priority remains our patients, communities and employees.</font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We will continue to monitor the overall situation closely as it applies to all our partners and share updates appropriately. </font></div><div style="text-align:justify;"><font><br></font></div><div style="position:relative;width:100%;height:36pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">About Galafold</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Galafold</font><sup style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;(migalastat) 123 mg capsules is an oral pharmacological chaperone of alpha-Galactosidase A (alpha-Gal A) for the treatment of Fabry disease in adults who have amenable&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">GLA</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;variants. In these patients, Galafold works by stabilizing the body&#8217;s own dysfunctional enzyme so that it can clear the accumulation of disease substrate. Globally, Amicus Therapeutics estimates that approximately 35 to 50 percent of Fabry patients may have amenable&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">GLA</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;variants, though amenability rates within this range vary by geography. Galafold is approved in over 40 countries around the world, including the U.S., EU, U.K, Japan and others.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">U.S. Indications and Usage</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Galafold is indicated for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene (</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">GLA</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">) variant based on&#160;</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">in&#160;vitro</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;assay data.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This indication is approved under accelerated approval based on reduction in kidney interstitial capillary cell globotriaosylceramide (KIC GL-3) substrate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">U.S. Important Safety Information</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Adverse Reactions</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The most common adverse reactions reported with Galafold (&#8805;10%) were headache, nasopharyngitis, urinary tract infection, nausea and pyrexia.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use in Specific Populations</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There is insufficient clinical data on Galafold use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. Advise women of the potential risk to a fetus.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">It is not known if Galafold is present in human milk. Therefore, the developmental and health benefits of breastfeeding should be considered along with the mother&#8217;s clinical need for Galafold and any potential adverse effects on the breastfed child from Galafold or from the underlying maternal condition.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Galafold is not recommended for use in patients with severe renal impairment or end-stage renal disease requiring dialysis.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The safety and effectiveness of Galafold have not been established in pediatric patients.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">To report Suspected Adverse Reactions, contact Amicus Therapeutics at 1-877-4AMICUS or FDA at&#160;1-800-FDA-1088 or&#160;</font><font style="background-color:#ffffff;color:#01b0f1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">www.fda.gov&#47;medwatch</font><font style="background-color:#ffffff;color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</font></div><div style="margin-bottom:7.5pt;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For additional information about Galafold, including the full U.S. Prescribing Information, please visit&#160;</font><font style="background-color:#ffffff;color:#01b0f1;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">https&#58;&#47;&#47;www.amicusrx.com&#47;pi&#47;Galafold.pdf</font><font style="background-color:#ffffff;color:#333333;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">E.U. and U.K. Important Safety Information</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Treatment with Galafold should be initiated and supervised by specialists experienced in the diagnosis and treatment of Fabry disease. Galafold is not recommended for use in patients with a nonamenable mutation.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Galafold is not intended for concomitant use with enzyme replacement therapy.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Galafold is not recommended for use in patients with Fabry disease who have severe renal impairment (&#60;30 mL&#47;min&#47;1.73 m</font><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">2</sup><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">). The safety and efficacy of Galafold in children 0&#8211;15 years of age have not yet been established. </font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">No dosage adjustments are required in patients with hepatic impairment or in the elderly population.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">There is very limited experience with the use of this medicine in pregnant women. If you are pregnant, think you may be pregnant, or are planning to have a baby, do not take this medicine until you have checked with your doctor, pharmacist, or nurse.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">While taking Galafold, effective birth control should be used. It is not known whether Galafold is excreted in human milk.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Contraindications to Galafold include hypersensitivity to the active substance or to any of the excipients listed in the PRESCRIBING INFORMATION.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">It is advised to periodically monitor renal function, echocardiographic parameters and biochemical markers (every 6 months) in patients initiated on Galafold or switched to Galafold.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">OVERDOSE&#58; General medical care is recommended in the case of Galafold overdose.</font></div><div style="position:relative;width:100%;height:36pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="height:72pt;width:100%;"><div><font><br></font></div></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The most common adverse reaction reported was headache, which was experienced by approximately 10% of patients who received Galafold. For a complete list of adverse reactions, please review the SUMMARY OF PRODUCT CHARACTERISTICS.</font></div><div style="text-indent:-18pt;padding-left:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Call your doctor for medical advice about side effects. &#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">&#160;</font></div><div style="padding-left:36pt;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For further important safety information for Galafold, including posology and method of administration, special warnings, drug interactions and adverse drug reactions, please see the European SmPC for Galafold available from the EMA website at </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">www.ema.europa.eu</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">About Amicus Therapeutics </font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amicus Therapeutics (Nasdaq&#58; FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases. For more information please visit the company&#8217;s website at </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">www.amicusrx.com</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and follow on </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Twitter</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and </font><font style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">LinkedIn</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">Forward-Looking Statements</font></div><div style="text-align:justify;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This press release contains &#34;forward-looking statements&#34; within the meaning of the Private Securities Litigation Reform Act of 1995 relating to preclinical and clinical development of our product candidates, the timing and reporting of results from preclinical studies and clinical trials, the prospects and timing of the potential regulatory approval of our product candidates, commercialization plans, manufacturing and supply plans, financing plans, and the projected revenues and cash position for the Company. The inclusion of forward-looking statements should not be regarded as a representation by us that any of our plans will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong and can be affected by inaccurate assumptions we might make or by known or unknown risks and uncertainties. For example, statements regarding corporate goals and the attainment of such goals, including as they are impacted by Covid-19 related disruption, are based on current information. The potential impact on operations from the Covid-19 outbreak is inherently unknown and cannot be predicted with confidence and may cause actual results and performance to differ materially from the statements in this release, including without limitation, because of the impact on general political and economic conditions, including as a result of efforts by governmental authorities to mitigate Covid-19, such as travel bans, shelter in place orders and third-party business closures and resource allocations, manufacturing and supply chain disruptions, limitations on patient access to commercial product or clinical trial sites and investigational product or other clinical study disruptions. With respect to statements regarding projections of the Company's financial outlook, actual results may differ based on Covid-19 related disruptions and other market factors, including the factors above, and the Company's ability to execute its business continuity, operational and budget plans. In addition, all forward-looking statements are subject to other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2019. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and we undertake no obligation to revise or update this news release to reflect events or circumstances after the date hereof.</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONTACT&#58; </font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Andrew Faughnan</font></div><div style="text-align:justify;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Director, Investor Relations</font></div><div style="text-align:justify;"><font style="background-color:#ffffff;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">afaughnan&#64;amicusrx.com</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </font></div><div style="text-align:justify;"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(609) 662-3809</font></div><div style="text-align:justify;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">FOLD&#8211;G</font></div><div style="position:relative;width:100%;height:36pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>fold-20200323.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:16009264-c148-47e0-ba43-b96e1478488b,g:8a3733b3-3c4d-4fad-9c12-2a373ff36d7c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:fold="http://www.amicustherapeutics.com/20200323" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.amicustherapeutics.com/20200323">
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200323_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200323_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200323_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="fold-20200323_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.amicustherapeutics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>fold-20200323_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:16009264-c148-47e0-ba43-b96e1478488b,g:8a3733b3-3c4d-4fad-9c12-2a373ff36d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="simple" xlink:href="fold-20200323.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>fold-20200323_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:16009264-c148-47e0-ba43-b96e1478488b,g:8a3733b3-3c4d-4fad-9c12-2a373ff36d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="simple" xlink:href="fold-20200323.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended" id="i3de1eab6daed4f52a445cfe15fdd7806_7a8be92e-860b-4d33-a5a4-6a7c04f3c503"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>fold-20200323_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:16009264-c148-47e0-ba43-b96e1478488b,g:8a3733b3-3c4d-4fad-9c12-2a373ff36d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_WrittenCommunications_dbc0e4b8-20b1-4e77-9789-0b863b067a1f_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_640705a1-c4f3-41df-b6a9-d4a21e5b7464_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_b9303307-d903-4369-a0bf-0ca6128a382d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_0c142439-a45e-4fb4-839c-174ff9496450_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_40b5eaca-e206-408e-8a17-0b0dcac28723_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d1fdbefc-06b7-47e9-b595-66c9f4c1dc0c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_14222b09-d9d8-4b67-8a79-cfd98562d851_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_fd37609b-7961-441a-a493-ff5ee0edf050_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_62e0cf97-c476-4ecc-bb21-728bb1ff1f2e_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_4584fb4a-1974-4feb-8092-b755d8de6ab0_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c0b018d3-9e0f-4867-960a-4fc5ea5b54f5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c4b0f503-86bf-4840-b033-b1c83d047b9f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_bcb3f371-b964-4f81-900d-54718e753fa0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a37f6a8c-c89b-457c-9649-6f6a9e433f15_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_be3d9add-7647-43e1-83eb-5db6b5f43c73_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of each class</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5538896f-2404-4a4e-808b-f976e27b7dcd_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_4e37e3a0-5fe4-46a1-8210-be5af1e79d93_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_dc706c1d-cf9c-44ac-afd9-658f0e2e59a7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_434017ec-be4c-4dcf-ad91-f95bb9cd6f9d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_470f4fae-ddc2-4435-a37c-d46a9d536e6d_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_d50ef9e4-747b-452f-b08d-147721510b98_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2dd1d831-a127-4f6d-8757-602d55bb7c1e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_1d7d28b4-f7ae-4c38-9c97-15583839cf6d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>fold-20200323_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:16009264-c148-47e0-ba43-b96e1478488b,g:8a3733b3-3c4d-4fad-9c12-2a373ff36d7c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="simple" xlink:href="fold-20200323.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.amicustherapeutics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_fc8b8992-dbf8-4689-93c0-d11c93c6ebd7" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_DocumentType_fc8b8992-dbf8-4689-93c0-d11c93c6ebd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_0597182b-bcde-4782-bfba-33b0fba9d989" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_DocumentPeriodEndDate_0597182b-bcde-4782-bfba-33b0fba9d989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5cb88e3b-afac-4f00-8d70-2f23aa06bd72" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityRegistrantName_5cb88e3b-afac-4f00-8d70-2f23aa06bd72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_ef90b6a8-8582-42f3-b8a6-c70b822de261" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityIncorporationStateCountryCode_ef90b6a8-8582-42f3-b8a6-c70b822de261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_217ae4a5-6f21-4eae-b8aa-eee195121156" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityFileNumber_217ae4a5-6f21-4eae-b8aa-eee195121156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_84c3d870-2402-4dd0-b56e-53f1af64e419" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityTaxIdentificationNumber_84c3d870-2402-4dd0-b56e-53f1af64e419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b091a5b2-d58c-4595-bf1e-5858147bb643" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityAddressAddressLine1_b091a5b2-d58c-4595-bf1e-5858147bb643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_4b1cc213-dac4-445f-b92e-e015e8c169f0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityAddressCityOrTown_4b1cc213-dac4-445f-b92e-e015e8c169f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d700c1cd-4b44-47b7-bf71-50db45b8ea4b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityAddressStateOrProvince_d700c1cd-4b44-47b7-bf71-50db45b8ea4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4e99b625-c33c-4495-a6b9-c36f9541160c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityAddressPostalZipCode_4e99b625-c33c-4495-a6b9-c36f9541160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_aca0826b-04a5-4d1c-b358-4d8d6f2cf9ef" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_CityAreaCode_aca0826b-04a5-4d1c-b358-4d8d6f2cf9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_91d77b66-50f8-4de0-891e-f0e89079bfd3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_LocalPhoneNumber_91d77b66-50f8-4de0-891e-f0e89079bfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_4b6893ab-04e9-4520-bb7f-b07d0b1fefc2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_WrittenCommunications_4b6893ab-04e9-4520-bb7f-b07d0b1fefc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_fbe531ef-2420-49b1-99b2-aa322af395d8" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_SolicitingMaterial_fbe531ef-2420-49b1-99b2-aa322af395d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_08e99ff5-337f-4698-a3cc-28586d0f2c43" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_PreCommencementTenderOffer_08e99ff5-337f-4698-a3cc-28586d0f2c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_6c57c5ad-cb33-4581-a8f9-00fafb204ff3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_6c57c5ad-cb33-4581-a8f9-00fafb204ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_db386fc5-aea6-46eb-b5a7-85c975583a21" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_Security12bTitle_db386fc5-aea6-46eb-b5a7-85c975583a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_dc4c31dd-c893-4675-9791-215f0f42269f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_TradingSymbol_dc4c31dd-c893-4675-9791-215f0f42269f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_dfb59cfa-319e-4c9f-9cdd-2c3f683ec7e6" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_SecurityExchangeName_dfb59cfa-319e-4c9f-9cdd-2c3f683ec7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_55496f46-5076-4a83-9ea3-f2e0bf92941d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityEmergingGrowthCompany_55496f46-5076-4a83-9ea3-f2e0bf92941d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_904c65e8-e7d8-4631-b627-6f73cb1c881c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_EntityCentralIndexKey_904c65e8-e7d8-4631-b627-6f73cb1c881c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9b322dfc-f3ff-43a0-82db-a7299fdd86e3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_860c108d-77f4-43d4-92f5-04d6868710dd" xlink:to="loc_dei_AmendmentFlag_9b322dfc-f3ff-43a0-82db-a7299fdd86e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>image01.jpg
<TEXT>
begin 644 image01.jpg
M_]C_X  02D9)1@ ! 0$ 1P!'  #_VP!#  (" @(" @(" @(" @(" P0# @(#
M! 4$! 0$! 4&!04%!04%!@8'!P@'!P8)"0H*"0D,# P,# P,# P,# P,# S_
MVP!# 0,# P4$!0D&!@D-"PD+#0\.#@X.#P\,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" )@!Q,# 1$  A$! Q$!_\0
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M4V*"HL+2!Q5#<Q<D8^+Q)43_V@ , P$  A$#$0 _ +_
M
M
M
M
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M"HF9MW\\3'J]OTH:C$Y?B,-\[;JIZ8T;;#8_#XGYJY35T3JSHQ&6
M
M
M
M
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MQ$*TSC9O%9;XU4<*C[4;NOF[O.LC*-H\+F/BTSP:_LS[N?O\R4)'V_
M
M
M
M
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MRQ*O1K+G\MO]^[T_=-TW>E=;0;&Q.M[!QQ\M'^/P[.9860;83&EG%SQ<E?\
ME\>WG6Z4M535M-3UM%405='5QLFI*N%Z21RQR)S,>Q[=T<UR+NBH5I53-,Z3
MO6335%4:QN?N?'T
M
M
M
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MT,B<S)(WMW145%Z*5!<MU6ZIIJC286W;N4W*8JIG6)?><',
M
M
M
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MIIJC286[;N4W*8JIG6)?><',
M
M
M
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M34E7"])(Y8Y$YF/8]NZ.:Y%W14*@JIFF=)WK<IJBJ-8W/W/CZ
M
M
M
M                                                 ,;R_+L>P/&K
MQE^5W*&T8_8J=:FY5\FZHUJ=$1K4W5SG*J-:U.JJJ(G4[\-AKF)N1;MQK5.Y
MT8G$V\-;FY<G2F-[GAXE>(W(^(/,/="I26U8;9'R18AC7-TBB<O6HGVZ.GE1
M$YE[D39J=$W6[LAR.WE=G2..N?*GW1YH4KGN=W,SNZSQ41Y,>^?/*-IO6C
M                !9YP.<6CL7JK?HSJ5=-\9KI$APC(JI_]CIG[(VBF>]>E
M.]?K:_$<NWP%]"O]KMF_#1.*L1XT>5'VO/'GY^?IWS[9/:/P,QA;\^+]6>;S
M3YN;FZ-US!5JSP
M
M
M
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M+:#Y33\FO3X\>3/VHYNF/7'6LE((G(
M
M
M
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MK+,1P?J3QTSYN;IC\5V[/YS3F6'X7UXXJH]_1/X)+FA;T
M
M
M
M                                        %>W'%Q0KI=89-,<'N'9Z
M@Y/3?]*W&!WIVBW2HJ<R*GP9YDZ,\6MW?T7D4FNR.S_RROY1=C]73N_BGX1R
M]G.AFUF?_(Z/ 6I_65;_ .&/C/)V\RC5555557=5[U+=5*_P
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MNG@Y.YR+U1=T7J4/B,/7A[E5NN-*J9TE>>'OT7[<7*)UIF-8>^=+N
M
M
M
M                                              $?^)#7BRZ Z>5>
M35?85N27+FHL-L+UZU=:K=^9Z(J+V,*>G(O3ILW?F<TW619/7F>(BW'DQQU3
MS1\9Y/P:;/,WHRW#S<GRIXJ8YY^$<OXN<?)<DO>87^[Y1DEQJ+M?K[525ETN
M,WPI99%W5=DV1$3N1$39$V1$1$+SL6*+%N+=$:4QQ0I"_?KOUS<KG6J>.7AG
M:Z@               !E>&X/E^H5\I\;PG'KIDMZJ>L=#11J]4;XOD=\&-B>
M+G*B)XJ8^*Q=K"T<.[5%-/G9&%PEW$U\"U3-4^99YHYY-E7MIKQK;D3XE7ED
M^HRP2)NGCRU5<YJI[%;"WYI2O\TV[^KA*?YJO=3\>Q/LLV&^MBJOY:??5\.U
M9-I_I%IGI;1I18#A=BQM.3DFK*>%'5<R)_=JN3FFD_EO4@>-S/$XR=;U<U=W
M5&Z$YP>6X;!QI9HBGOZYWR^76W&_JOT>U.QI&*^:[8S<X:1J-YE\X\V>Z!>7
MQVD1JG+*;_@,7:KYJH[->/U..:V/#X2[1STSVZ<7K<OAZ"4$   %H?D\.(!;
M)>9M#,GK-K3D,LE9@D\J]*>OVYJBCW7N;4(G.Q/[HBIU=(5]MODOA*/E=N..
MGBJ\\<D]7+YNA/\ 8K.?!U_)+D\4\=/FGECK[^E<B5<LX
M
M
M
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M7HG?N4/GF5SEV*JM?5WT^>F=W9NGH7IDF9QF&%IN_6W5>:J/COZV]C3MN
M
M
M
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M2XKP57DW.+^;ZOPZU\Y3JWP
M
M              'DUE^L5OF;3U]ZM-#.Y[8VP5%1%&]7N3F:U&N<B[JG5$.R
MFS75QQ3,NNJ]13Q3,0]""H@JHFSTT\-1 _?DFB<CVKLNR[*G3O.$Q,<4N<3$
M[G['Q]
M
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M_(,779Y->+T9XX^'2OC)<P^782B[RZ<?I1O^+=1JFT
M
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MM5317&DQOA9=J[3=IBJB=8GE>F<',
M
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MOC1TQQ3ZM.Q<*5BLP
M
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MZ)[^E=.54M(
M
M "FORAW$ M]O<6AV,5N]HQV5E7G4\3O1J+ALCH:3=J[*VG1>9Z?W143HL9:6
MQ&2^#H^5W(XZO)\T<L]?=TJPVUSGPE?R2W/%3Y7GGDCJ[^A5^6 @(
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M/%V[O)$\?1/%/J=/"*BHBHNZ+W*>?U]O]
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M\)5IPHG2=/5ZDE30MZ
M              J-\IYF-0M5I?I_#(YM(V*LR"XP^#Y'*E+2N_D(DW\XLO\
MT_PL:7;W+Q4^^?<K?;W$SK:L]-7NCWJG2QU=     ].S7>OQ^\6J_6J=::Z6
M2L@K[;4IWQSTTB2Q/^AS44X7;=-VB:*MTQI/1+G:N56ZXKIWQ.O8ZI\;O4.2
M8[8<BIFJRGOUNI;C3L]3*J)LK4_$X\ZW[4VKE5$\DS'8]"V+L7;=-<<L1/:]
MHZG:
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M)9(:"%CE7JO7=/6>>\TKBO%W:HY:ZO:E?^6431A+5,\E%/LPV08+.
M
M                                        '\N<UC5<Y4:UJ;N<O1$1
M .=KB_UWDUPU4K9;75NEP;#UEM>'1-7>.5B._9%:GMJ7M14^T1B+U0N_9C)_
M]NPL<*/UE7'5[HZN_52FTN;_ .X8J>#/ZNGBI]\]?=HBD2-'0
M /IHZ.KN-926^WTM16U]=,RGHJ*!BR2RRRN1K(V,;NKG.<NR(A\JJBF-9W0Y
M4TS5.D;Y7^<'_"_1:%XLF09)3T]5JAD\#5O-3\)+;3.V<V@A=W=%3>5R?"=T
MZM:U5IC:?:"<QN\"CYJG=_%/VI]WXKCV:R",NM<.OYVK?YH^S'O3/(JE
M       5R^4RI6OT6PNMYEYJ?-::%&>"I-;J]RK]'9DYV!J_]VN/_C_NI0C;
MNG_TZ)_C_MJ4BELJI      NC\F;F2W+3O/<&FDYY<5O<-SI4=X4]UAY>1OL
M22D>[YW?,55M]A>!B+=[[5.G73/PGU+2V#Q7"P]RU]FK7JJCXQZUF) D[
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MWVS=]E]IYZQ6'JP]VJU5OIG3L>@,-B*<1:IN4[JHU[62G0[P
M                                          *[?*-:7566:6V34"UT
M_;UVF];(MS8UOI>YEQY(YG].J]E+'$OL:KW=-E)OL-F$6,559JW7(XO2C=VQ
MKZD*VWR^;V&IO4[[<\?HS\)T]:CTMM4X    -MZ%Z95NKVJV&X)2Q/=372N9
M)?)V_N%N@7M:R55]D351OK<J)XFMSC'Q@<+7>GDCB]*=WK;+*,!..Q5%F.6>
M/HC?ZG3M'''%&R*)C(XHVHV.-J;-:U.B(B)W;'G^9U7W$:/[
M
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M51V3Q=^B9;$8CP>-FC[5,]L<?=JO4*A6V
M               AKQTZH?J=:#WNVT50D-^U#D^IVW-1?32GG:KJZ3;OV[!'
M1[^"O:2G9#+_ )5CJ:I\FCQIZ?J^OCZD8VMS#Y+@:HCRJ_%ZOK>KBZW/J72I
MD    %WODX=3ER72Z]Z<U]0LEQT\KNTMS7+U]S+DKY6(GKY)VR[^I%:G3H5+
MMUE_@L53?C=7''Z5/X:+7V'Q_A<-58G?1/\ 35^.JQ<@Z;
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MI]H/]RN\"W\U3N\\_:^'XKAV9R#_ &VWPZ_G:M_FC[/Q_!,XBJ4
M
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MGZ9Y.U+]E<A^77/#78_5T_U3S=$<O8OA:UK&HUJ(UK4V:U.B(B%.K>?T
M        $%_*'PQR\.=6][>9U/D-KDA7Y+E61F_\URH2[8B=,QCT91+;6/\
M^?\ S0H3+D4^     !O;ACR7ZDN(#22]+(L4?U1TE!42I\6&Y+YC*J^SDG7?
MV&HS^QX? 7J?X9G[OC>YM\AO^!Q]FK^*(^]Q>]TO%"+V
M                          4+^4#U17.=:WXE15':6/3*F]RXVM7=KKC/
MRRUS_G1>2)?;&7'L7E_R?!>$GRKG'U?5]\]:H-LLP^48SP<>3;XNOE^'4@F2
M]$0    2IX,]3OU,->\2JJJH["QY8Y<:OWR>SKW-2!Z^I&5+8G*OR44CNU.7
M_+,!7$>53XT=6_U:I#LOC_DF.HF?)J\6>O=Z]'164>NP
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MU?D[D)S//,5F,_K:N+[,<5/9\=933+,DPN7Q^JIX_M3QU=OPT;R-0VP
M
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MZ?[B9B/;^13SE<HFBJ:9Y'HBW7%=,51ROO.#F
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MVFI;4
M
M                                                      PK4;.[
M)IE@^39YD4J1VK&J*2KF9OLZ9Z>C# S?X\TBMC;[50RL#@Z\9?ILT;ZI_,]6
M]BXW%T82S5>KW4Q^8Z]SF-SS-+WJ+F61YQD<_;WG)JZ2MK%3?E9SKZ$3-^YD
M;$1C4\&HB%_X/"T86S3:HW4QI^>G>H7&8JO%7JKM>^J=?ST,2,EC
M    ^FDI*JX5=+04--/65M;*R"CI(6J^2661R-8QC6]5<Y5V1$/E544QK.Z'
M*FF:ITC>Z)>$[A[H]!-.H::X0P29[D[8JW-+@W9W)(B+V5$QR?$IT<J=/A.5
MSNY4VH_:3.IS+$:Q\W3Q4_'K[M%U[.Y+&6X?2?G*N.KX=7>E,1Y(
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M#3R^-'3NGU:=BX K%98
M
M
M       !3CY1O6];M?+7HC8:M?,,=='=,U5BIM+72,WI*953^XQOYW)W<SV^
M+"T-ALIX%$XNN..KBIZ.6>N>+J\ZLMM\VX=<82C=3QU=/)'5''U^95R6$K\
M           "U'R>O#JVZ5?ZN^74#9+?;99*?3RCF3=LM5&JLGN&R^$*HL<?
MV_,[HK&J5WMMGG CY';GCGR^CDIZ]\^;I6%L7DG#GY7<CBCR.GEJZMT>?H7!
ME8K+               (.>4,^QQN7W^M7YQQ+=B?I&/1E$]M/H^?2A0<7*IX
M      !T,<"EU]T^&+3YCGH^:U2W6AF7T>G)<JE[$5&]VT;V]_7Q\2D]K[?
MS.YY])_IA=&R-SAY;;\VL?U2EX1E)0
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M%<15&Z7UG%R
M
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M:^EHY^B>K>5?RE0[=T<''Q//1'?5'N6WL/7PL#,<U<]U,K "%ID
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M ";'37'DW/&Z_K>OCZUQ['X_Y3@HHGRK?B]7U?5Q=2;1$TJ
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M^<MU4],3#;6,PP]_YNY35T3$L\,-E@
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MGNM5=!5\J?;I"]RM^932XC!W\/.EVBJGIB8;G#XRSB..U735T3$LN,9D@
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MI_\ 8M3_  ]T_BM#8*K_ ->[3_%WQ^"S@@">@
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M\T+?\(1+;/+_ )3@O"1Y5OCZOK?'J2S8['_)L;P)\FYQ=?U?AUK\BFEP@
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M^&J?97M=A,9XM?ZNOS[NJKXZ)M(J*B*B[HO<I$TK?Z
M              -&<1NL%)HAI/D>:N6)]Y5GN?B=&_;WZZ5*.2#HO>V/997I
M\EBFWR/+)S'%4VN3?5Z,;_ATRU.=YG&7X6J[R[J?2G=\>IS3UM95W&LJ[A7U
M$U975TSZBMJYG*^2665RN>][EZJKE7=5+ZIIBF-(W0HJJJ:IUG?+YCZX@
M        L(X =!/U0L\?JAD5'VF(Z=U#'6R.1N\=9>MD?"WKWI3(J2K]MV?>
MFY"ML\Y^2V/D]$^/<W^:G\=W:FFQV3_*;_RBN/$HW>>K\-_8O,*B6RQ:ZYOA
MUDW;=<GL5#(G[A)4Q]IT_O:+S?D,JU@;]WR:)GJ8MW'6+7EUQ'6P2NU\TNHE
M5K<@DK7IWMIJ6H=_XG,:W\IGT9!C*OJZ=,PU]>T&#I^OKT1+'I^)?3R+?LZ7
M)JK9=D[.FB3?V^G.PR*=F<5/+3V_@QZMI\+')5V?B^7^J?P'_NC+_P#,4O\
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M$IY\?G23?O[9MQ;MM[.S*T_U"IX[$^E_:LG8"KBOQZ/]RU\KA8@
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MFG-%RKS3Y-),C_!$AHY6JGT]H3W8"G_V;D_P^^$$V]J_]:W'\7N4N%JJM
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ME=G(P5'A[T?K9_HCXSR]G/KSVIVBG&U^!M3^JC^J?AS=O-I 0F:'
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MBE??Z@1^ILS_ !3W)_L#/ZZ['FCO7(E7+.
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MG0S1.[_28Y$7JB[HOBG5.A.+-^B]1%=N8FF>6$)O6:[-<T5QI5')+QCM=0
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M$<<^ITWP0PTT,--3Q,AIZ=C8X(6)LUC&ILUJ(G<B(4#,ZSK*^8C2-(?J?'T
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MOK&*O^+E:B>Q$*+VGQ'A\QNSS3P?N\7N7ALSA_ Y=:CGC7[W'[TES0MZ
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M=(GKYG]DU%^U<GK*SV]S#6:,-'I3W4^_U+)V$P&D5XF?1COGW>M:Z5RL0
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M\JM:OP2]-G,J_P!NPE-$^7/'5T\W5N4?M%FO^X8N:X\B.*GHY^O>C4;YH@
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MH=G+F65<*GQK4[IYO-5\>5;^S^T5O,J>#5XMV-\<_GCX<B7I&4E
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MS(CH=P     '+?J[^VQJ?^%MZ_3ICT+EG[+:]"GV8>?\R_:KOIU>U+79FL(
M  -U\-U/%4Z_Z,QS(KFMS&SRHF^WI15<<C?_ !-0U6>SI@+_ *%7<VN1QKC[
M/IT][II*"7P  (#>4=^Q]H_PMMOYBK)EL+](3Z$]\(?MQ^P1Z<=TJ)"X%1
M !F."Y_F.FF14F58-?Z_'KY2>BVKIG=)(U5%=%-&[=DC';)NUZ*B^HQL9@K.
M+M^#O4\*G\[N9DX3&7L)<\):JX-7YW\ZV[1;RC6(WYE)9=9;4N'7?9(URJW,
MDJ+7,[Y4L*<\]/O[.T;XJK4*TS78:[;UJPL\*/LSQ5=NZ?5UK(RO;>U<TIQ4
M<&?M1QT]F^/6L8QS)\<R^UP7S%;]:,CL]3]8N=MJ(ZF%WK3GC5R;IXIWIXD'
MOX>Y8JX%RF:9YIXDWL7[=^GA6ZHJCGCC>Z=+M
M            01X]M;OU-=+%PFR5O89?J6V2A;V:^^4]I:FU;-[.T14A;]TY
M6]6$PV-RGY7BO"U1XEOCZ:N2/?U>=$=L,U^287P5,^/<XNBGEGW=O,H9+B5
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M*USJ5VBR"O++O%QVJO)G^V?/W]JYMGL^IS.UQ\5RGRH_NCS=W8E>1Q(@
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ML7Y3&2N?_)-[LUA/E.86J9W1.OW>/W:-'M)BODV7W:HWS&GWN+WZN;HO51P
M    '2CPI6!N-\.>D%N:U&)48]!=-NG?=5=<%7IZ_."A]H[WA<QO3_%I]WQ?
M<O39VSX++[,?PZ_>\;WI!FE;D               YYN.R>6;BDU)CD=S,I8[
M+% FR>BU;/12;?SGJI=NQ\:97:_F]NI2VUTZYG=_E]BE$0DJ-@    ZO<?\
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M7;)S-5';)OL45FN67,NOS9KZIYXY)_/*O'*LSMYA8B[1UQS3S-M&M;$
M          Q[+,FM6&8QD&6WN9*>T8W;ZBXW"551/>J>-9%1N_>Y=MD3Q7H=
MV&L58B[3;HWU3IVNG$7Z;%NJY5NIC7L<O&=YA==0,SR?-KV]77/*+E47&J;S
M*Y(^V>KFQ-5?BQMV8WU(B'H3!X6G"V:;5.ZF-/STJ Q>)JQ-ZJ[5OJG5B9D,
M< O8\G?IG]1^C%3FM9!V=VU+KUJV*J;.2W4*OIZ1J]-^K^VD3UM>A4&V^/\
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M5#MM3IF'\L>] \F"(     ZO<?\ [ V3^(4WYIIYQO>75TO1-GR(Z'KG6[
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MAFAD3F9)&]NZ*BHO12I[ENJW5--4:3"U;=RFY3%5,ZQ+[S@Y@
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MSIW)\)?9W)[5ZDAPN"IL\>^6CQ&+JN]#4YFL0
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M<MYZ%>?P    63>3*_;8S[\$E_3J8@FWW[+;]/\ ME.=@_VJYZ']T+KBJ%J
M  !39Y3UDR9KI8]4?YNZR5S8W?%YTJ6<^WMV5N_T%H_Z?_,W?2CN5CM]KX:U
MZ,]ZKXL%      >OC_\ 9ZR?Q^F_.M.N]Y%70[+/EQTNKT\XO1(
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MK^J4M*WI# SY$;?!/RKXDELV*;5.E+0W;U5V=98P=KJ
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M]J6J38M<   &\N&?[(+1O\+;9^?::C/_ */O^A/<VV1?M]GTX[W3$4(O<
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MRWY!C:[<>3/'3T3\)UCJ7EL]F/R[!T7)\J.*KICX\4]:1)I&[
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M?!/_ *DGM6J;=/!I1^Y<FN=9>*<W
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M0VTS#Y/@O!QY5SBZH\KW1UI=L;E_RC&>$GR;?'USY/OGJ7TE.+?
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M1+*B[^I^Z'GS-+/@<7=HYJZN]?\ E=WPN$M5\]%/<V48#.
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M-5>S@B3X,<:+X)^5>I*+-FFU3P81Z[=FY5K+&3M=0
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MU7 ?Q0TZL2+3VDKN;?=8+S:4Y?G[6KC_ "';3MAED_\ )I_+5\'75LAF<?\
M'_53\6/U?!AQ-T2S)-I1=7]@F[^PK+?4;]-_1[&J?S?1N=U.U665?\T=DQ[G
M35LOF5/_ !3VQ/O8O6<+_$-0_7]'<]?LQ7_L>@DJ.B?X'GZ^SO,BG:#+ZO\
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MG1Z/>=0    3,X!?LF\._B%X_0)B+;9?1E?33[4)1L?])4=%7LRZ""EER@
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ML&OUVAC5.2LPZX13I]JE712)^5B$+V[IUP$>G'=4F6PU6F.GT)[Z5ZA4*VP
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M^+J^K\.I. B25@  !Y&0?V!O?\0J?S3CLL^73TNN]Y$]#E"/1SSL    "7G
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ME.]ZK_@T('MW@/"8>F_&^B=)Z*OA.G:G6PV/\'B*K$_7C6.FG\->Q=852M,
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M_GS6QP;;[?7ZZ*+?Z.;<U>>4\+ 7_0J]F6TR2K3'6?3I[X=-Y0*^0
M    8?FV 89J/9)\<SG&[7DUGGWWI:R/F5CEZ<\,B;/B?ZG,<CD]9DX3&7L)
M7P[-4TSYOSQ];&Q6#LXJC@7:8JCS_GBZE+G%/P1W72&EK<]T[FKLDT[B=VET
MH)DYZ^SM<J^D]6I[]3I_=-D<WXZ*B*\M79W:RG'3%F_XMSDYJOA/FY>3F5;M
M!LI5@8F]9\:WR\]/QCS]O.K^)HAH   3^\F]!+-K_=)(V\S*7#KC+.NZ>BU:
MJBCW_G/1"&;=3I@(]..ZI,MAXUQ\^A/?2O6*@6V
M 5"^4@UL;55EFT.L54O9VYT5ZSAS%Z+,]N]#2.V^2QRS.1>GI1KWH69L+E.D
M3BZ^7BI_NGW=JMMN,UUF,)1R<=7NCW]BJ4L978           ,KPG%ZG,<EM
MMAI^9C*E_-63I^Y0,]*1_P"+N]NR'3B+T6J)J=MFUX2N*5DE'1TUOI*:@HX6
M4])1Q,AIH&]S&,3E:B?,B$4JF:IUE)(C2-(?2?'(  1AX@,^6D@;@]KFY:BK
M:V6_2L7JV%>K(/Y?PG>S;P<;?+,-K^LGJ:O,,1IXD=:(INVH
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MS8FKOXH4?M5COE685SR4^+'\N_UZKLV7P7R7 4<]7C3_ #;O5HE41U(0
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M&X/8(E794]**WP1O3KZG-5"@,[C3'W_^RKVI7UDLZX&Q_P!=/LPW :QLP
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MXAYU^4]M4[;V,]A:.P&*UM7;/-/"[>*>[UJQV]PNEVW>YXX/9Q^_U*NBP4
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M^58^K3=1XL=6_P!>JZ=E,#\EP%.N^OQIZ]WJT2Z(TD@
M   "G'RC^M+;M?;)HK8JQ'T..JR[YDL3NCJ^5BI2TSMO[C$Y9%3NWD;XM+0V
M%RK@458NN..KBIZ.6>N>+J\ZLMN,TX==.%HGBIXZNGDCJCCZU7)82OP
M      9[IMA[\URN@M3FO]SHE\YN\K?BT\?PDW\%>NS4^<QL7?\  VYGE=^&
ML^%KT6,1QLAC9%$QL<4349'&U-D:U.B(B$62-_8?0 !"_B"S);K?8,5HY=Z"
MP^G7(G<^L>G_ /&Q=OG5QOLLL<&GASOGN:7,+W"JX,<B.YM&N
M    /]1%<J-:BJJ]$1 -ZX3H1D>1)%77YSL<M3_2:V1N]7(GVL2[<F_K=_-4
MUV(S&BCBIXY]3/LX"JOCJXH2PQ7 L6PV%L=DMD4=1R\LMRE]\J9/7S2+W;^I
MNR>PTM[$UW?*EM;5BBWNAF1T.\     "'/$I(BY%CL.R[QVY[U7[N54_^TWN
M4^1/2TV9>5"-IM6M   #J,T<IF46D.E='%&L,=)A]CACB7?=K64$+43KUZ;>
M)Y[S2KA8N[/\=7M2O_+*>#A+4?P4^S#9!@LX
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MY_FEOA[_ (*-H:^7?_P;?2378.G7'U>:B?:I0S;FK3 T^>N.ZI1B6ZJ4
M%B/DT:A6:YY93K+R1U&#UJ]EOLCWLN-NVZ>*HBN_*0C;V/\ T:)_^2/9J378
M2?\ W:X_^.?:I7AE2+8   "*?&[5/I.%W525C6N5T-KA5%]4]WHHE7Z$<2/9
M*GA9G:Z_8J1[:NK3++O5[=+G7+O4F    "7W A4R0<46G43$8K:V&]0RJO>C
M4M%9+T^F-",[84ZY9<_E]NE)=D:M,SM_S>Q4Z%BDUT      0@XT.&/]6W%H
M\KQ*DB_5,Q&G?YA&FS5NE$F[W43E^6B[NA5>G,JM79';I+=E<_\ ]ON^#N?-
M5?TSS_'\$4VHR'_<+7A+?SM/]4<WP_%0A44\])/-2U4,M-4TTCHJBGE:K'QO
M8NSFN:O5%1>BHI<D3$QK"GIB8G27XGU\    !*3AZXK]0M *IMOHE3)\$J)>
MTN&&5LCFL:KEW?)1S;.6GD7Q]%6K\9JKLJ1[.]G,/F<:SXMS[4>_GCU^=(,E
MVBQ&6SI'C6_LS[N:?SHN@TBXK=&-9(:>&PY/3V7(Y=D?B-[<RCK^?Y,2.<K)
M_P#%.=[40JO,]G,9@/+IUI^U3QQ^'6M'+=H<'CO(JTJ^S/%/X]22!HF\   #
M3FJ.ONDVCM)+-G686V@KFLYH,>IW><W*;U(RDBW>F_RG;-];D-IE^38O'S^I
MHF8Y]U/;^9:S,,XPN!C];7$3S;ZNS\PJ)X@^//.-4:>X8KI]3U6 815M=#55
M"/\ ^EZ^%W1S9IHUY8&.3O9$NZ]45[FKL67DNQUC!S%R]X]?],=$<O3/8K;.
M=K[V,B;=GQ*/ZI^'1':C=P\:82:P:PX5@[HY'VNMK4JLB>WXEMI$[>J]+XO.
MQO(U?E.0WV=YA\AP==WETXO2GBCXM'DN ^78NBUR:\?HQQS\'3-##%3Q1001
M1P00,2.&&-$:QC&ILUK6IT1$0H.9UXY7O$:<4/T/CZ  (L<96E\NJ>@V54%!
M3+4W[%^7([!$U.9[I:!KNVC8B=5=)3OE:U/%RH2+9;,/D>.HF?)J\6>O=Z]$
M?VGP'RS UQ'E4^-'5O\ 5JYTB\%)      ?I#-+3RQ3P2R03P/22&:-5:]CV
MKNUS7)U1443&O%+[$Z<<);8-QQ<16#4T% F7P9;;Z9$;#2Y)3MKG[(FW6I18
MZEW\J52-8O9'+L1.O X,_P /%ZMWJ2/";69AAXTX?"C^+C]>_P!;:KO*7:[*
MQ6IBND['+OZ:4-RZ?-O<S7?H%@?MW.VG_!L?T[QWV+?95_FT9J)QA<0&I=+4
M6V[YQ466RU**V:S6&-MNB>UWPFOEB]_>U4Z*U\BI[.\V^!V8P&$GA4V]:N>K
MQOP]348W:;'XN.#57I'-3Q?CZT8S?M"R7#\1R#/,FLN'XM;Y;I?[_4LI;=1Q
M^+G=[G+\5C$W<YR]&M157HAT8K$V\-;JNW)TIAWX;#7,3<BW;C6J7NZK8*NF
M>H>4X$ZO;=)<6JTH:BX-;RMEE;&U9%:WP3F5=O9WG3EV,^5X>B]IIPHU=V8X
M3Y)B*K.NO!G1KTS6$   'N8S5K09)C]<U[(W45RI)VR/^"U8YFNW7?PZ'5B*
M>%;JCS3W.VQ5P;E,^>'5P><GH@  >5?;M3V"QWF^U>WFMEH:BOJ=UY4[.FC=
M*[KX=&G99MS<KBB.6=.UUWKD6Z)KGDC7L<I5=65%QK:NX5<BRU5=-)45,J][
MI)7*YR_2JGHRBF*8B(Y'GBJJ:IF9Y7RG)Q2DX8^)[)>'K(W-<RHOFG][E:N3
MXPCO21?@^=T?,J-9.U/7T>GHNV]%S8]G^S]O-+?-<C=/NGS=W?(,AS^YEESG
MMSOCWQY^_NORTYU/P;5C':?*,#R"BOMLE1$J&1KM44LBIOV-3"OIQ/3U.3VI
MNFRE-8[+[^"N>#O4Z3ZI\\3RKAP./LXVWX2S5K'KCICD9\8;,   #5NK^KV'
MZ*87<,RR^NCBBIV.;:;0U[4JKC5;>A34S'+Z3E\5[FINYW1#899EE[,+T6K4
M=,\D1SRU^99E:P%F;MR>B.69YH<V6HN=WS4[-\ESW))&R7C)JQU54M9OR1-V
M1D4,>_7DBC:UC=_!$+XP.#HP=BFS1NIC\SUSQJ,QN+KQ=ZJ]7OJG\QU;F%&4
MQ0"2_"GH=5ZY:K6FT5%,]^'8\^.Z9M5[+R>:1NW;3;_*J7)V:>.W,[XJFAVC
MS>,NPLU1Y=7%3T\_5O[.=O=GLIG,<5%,^13QU='-U[NWF='4<<<4;(HF,CBC
M:C8XVILUK4Z(B(G=L47,ZKPB-']@                    UQJWJ/:M)=.<
MKU O'(^#'J)TM+2*NRU-6_WNFIT_PDKFM]G?X&=EN!JQV(HLT_6GLCEGJA@Y
MECJ<%AZ[U7U8[9Y(ZY<QF1Y!=<KO]ZR:^U3ZV\W^MGN%TJW=[YZAZR/7V=5Z
M)X%_V+--FW%NCBBF-(ZE"W[U5ZN;E>^9UGK>*=KJ           !/#1#"_J7
MQ1EQJXECN^1(VIJ4<GI1P=>PC]G1>9?:NW@1S,+_ (2YI&Z&^P5GP=&O++=!
M@,T  8YEV0P8KC=WO]1LY+? KH8U^/*[T8F?RGJB';9M>$KBEU7;G@Z9J5IU
M=745]54UU7*Z>JK)7S5,SN]SY%YG*OSJI+*8BF-(1J9UG5\Q]?
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M42RXE3R?"_Z1N2)],<#5_P#$NWS&YRJUOKZFIS*[NH12-RU0
M #>^F6B]?E?87K(.VMF.KL^&/X-16)]IO\%B_*\?B^M-=B\?%OQ:>.>YGX;!
M3<XZMR:%JM-MLE#!;+3104%#3)M#30ILB>U?6J^*KU7Q-!77-<ZRW5-,4QI#
MT3BY         "N'4RYI>,^RJM:O,SS]]/&[UMIMH&K^)A*L)1P;5,(WB:N%
M<F6"F0Z  !^D44DTD<,+'22RN1D4;>JN<Y=D1!,Z/L1JZRJ>"*E@@IH&\D%/
M&V*%FZKLUB;(FZ]>X\W3.LZR]%Q&D:/V/CZ
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M5]+F^%4K4=WQ?KW=]/B4QMI1P<RJGGBGNT]RX]C:^%EU,<TU=^OO38(HE0
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M_5RJY:@S?.K^9W.%<GBY*>2/Q\ZW,IR:QEMO@VXX^6KEG\/,WF:AM@
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MW,I(HL2PK*\E=,NT?N9;ZBJ3V[NB8Y$1/%5[C&OXVQ8^<KIIZ9B&38P5^_\
M-T55=$3*5> \ /$!F+X9KY:[3I];'JBNJ;U4M=4*SQ5E+2]L_F]DG)\Y',9M
MG@+'D3-<^;=VSIZM4BP>QV/O^5$41Y]_9&OKT6":3^3YT=P1]+<\SDK-3[[
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ML,3G-3=4:ZX0(J_0G4U^;U<'!7I_@J]F6PRFGA8RS'\=/M0Z@CSZOT
M
M
M   /CK+?07&+L+A14E?!U]YJ(VRLZILOHO14[CE3753QQ.CC51%7%,:L+JM)
M]+*]TCJ[37 *QTK>65T]FH9%<W;;9>:%=^AETYCBJ=UVO[T_%BU9=A:M]JC[
ML?!XS=!-"V.1S=%M)FN:N[7)CEL145/_ &<[?]YQW[^Y]^KXNK_9\%^XM_=I
M^#)[=IWI_:']K:<%PZUR;[]I26REA7?;;O9&GAT,>O'8BORKE4]<LBC!6*/)
MMTQU0S(Q62               8]>,2Q7(O[8,9Q^^;ILONA105/3I_=6.]2'
M=:Q-VUY%4QT3HZ;N&M7?+IB>F-6&5&A>B-7*L]5HYI74S.VYII<>MKW+MW=5
M@W,N,WQL;KUS[U7Q8LY1@IWV;?W:?@]VU:::<6)\<EDT_P )LTD2-;$^AM5'
M3JU&ILU$6.)NVR'3<Q^(N>7<JGIF9][NMX##V_)MTQT1$,W,1E
M           ,0N>G^!7J19;SA&(W:5SN99*VVTL[E=W;[R1N,FWC;]OR:ZHZ
M)F&-<P=BYY5%,],1+%4T%T,1Z2)HOI.CT7F1_P!3MLWW]>_FYD_[SCOW]S[]
M7Q8_^SX+]Q;^[3\&36_3G3VTR=K:L#PRV2[[]I26NDA=OW=[(T]9CUX[$5^5
M<JGKEWT8'#T>3;ICJAF2(B(B(FR)W(8K*?Z
M-8ZR:F6S2#37*]0;IV<C;#1N=;J)R[>=5LOO=+3^OTY7-1=NYN[O S\KP%6.
MQ-%FGEGLCEGL8&9X^G X>N]5R1VSR1VN8Z^WNYY+>KOD5[JY*^\7VLGK[I6O
M^%+45#UDD>OSN<I?]FU3:HBBF-(B-(Z(4+=NU7:YKJXYF=9Z9>4=CK
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M?Q\/>^OL-+M'7P<NO3_#W\3<[.T<+,+,?Q=W&Z4"AUZ
M
M
M
M         !3-Y1_65M\R>R:,V:I1]OQ%6W;*E8NZ.N4\:I3PK_@8)%=\\FW>
MTM/87*_!VJL55OJXJ?1C?/7/<J_;C-/"7*<+3NIXZO2G=V1WJQ"?H$
M     "=' 7HG^J9JNS,;Q3=IB>F3H;E,CV[LJ;FY56A@Z_(<Q9G=_P !J*GI
MD0VQS;Y)A?!4^7<XNBGZT^[K\R6[(95\KQ7A:O(M\?35]6/?U>=?84XN  \#
M*<>HLKQ^ZX]<-_-KG L:O3O8]/2C>GM:Y$4R,+B*L/=IN4[X8^*P].(M56ZM
MTJM;U:*ZP7:X66Y1+#76V=T%2SVM7O3UHO>GL+3LWJ;U$5T[I55>LU6:YHJW
MP\P[74@AKY=5N&H573([>.S4E/1L^=6]N[\LI(\MHX-G7G:''U:W>AI8SV$
M         &?Z<8/59WD4-M;SQ6VFVGO%8G[G"B_!1?E/[F_C[D4QL5B(LT:\
MO(R,-8F[5IR+#Z*BI+;1TU!0P1TM'1QMAIJ=G1K&-39$0B]54U3K*0Q$1&D/
MJ/CD           #56K^:?4=B=0M+*C+S>>:CM7RF[I[[,GW#5Z?;*TS,#A_
M"W/-#$QE[P='GE7X29'P    2YX%K>E?Q0:<*]&.CH&W:KD:Y53X%KJD9MMX
MH]S5(UM?7P<LN^?@^U"2;)4<+,[?FX7LRZ&RDET@
M
M
M
M    #76K.HELTGTYRW4&[(V2GQNA?/!2JO+YQ4O5(Z:!%_OLSFL^DSLMP-6-
MQ%%FGZT]D<L]4,+,<;3@L/7>J^K';/)'7+F*R/(+KE=_O637VJ?6WF_UL]PN
ME6[O?/4/61Z^SJO1/ O^Q9ILVXMT<44QI'4H2_>JO5S<KWS.L];Q3M=0
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MUQW3/N3#8BCA8^9YJ)[XCWKW"GUN@
M
M
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MY/JBJHU^,U=TID7V+U?_ #?E(;K+<)_R5=7Q:G'XGZD=:+!N&J      L_\
M)AVM9<XU1O7Q;?8J*B7YZRI=(GA_ZMZ__P"J_P#]0+FEBU3SU3/9'XI]L%;U
MO7:N:F([9_!<J5:L\
M
M
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MPW&X,2QJTV&#D5:*%/.96_ND[O2E?]+E7Z")W[OA:YJ26S;\'1%+)SJ=H
M        -%:P:J1XE226&R3LDR:M9M)*U=_,HW)\-WVZI\%/Y2^&^QP.#\+/
M"J\GO8&,Q7@XX,;^Y!Y[W2.<][G/>]5<][EW557O55)"T;^0      7&^3!M
M'8XCJO?^7K<KO;:#G]?F,$LNW?X>=^K_ /JK_P#4"[K=LT<T3/;,?!9NP-O2
MU=KYYB.R)^*T<KU8
M
M
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M^Y"*IJ:BMJ)ZNKGEJ:JI>LE142*KGO>Y=U<Y5[U4D$1$1I#23.K\#Z^
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MOG>,Q>-BW=N:TZ3S?!<,5BLP
M
M        !CV6U]5:<4R:Z43TCK;;::VJI)%1'(V6&![V+LO1>J'=AJ(KNTTS
MNF8[W3B:YHM551OB)[E#']7UQ-_OQM']#T'_  2X_P!#<L^Q/WI^*H/TPS+[
M<?=CX))<)G%GK?JMK?C>%9KD=ON./7&DN,M52Q6ZDIW.=3TDDL?OD4;7)LYJ
M>)H=I-F\%@L%5=M4S%43'+,[Y;S9S:/&XS&TVKM6M,Z\D1NA;L5HLD
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MU+X/:H)8^SK[FGNA<$\>>=$5K5^Y8C47VD8QM[PEV>Q(<):\';ALXQ&4
M     /U@@GJIHJ>FAEJ*B=R,A@C:KWO<O1$:U.JJIQJJBF-9?::9JG2$3M3-
M=E_95APB56JBNBJ\B[E]3DID_P#O_F^#C=X3+OK7.SXM1B<=]6CM16>]\CWR
M2/=))(JN>]R[JJKWJJFY:I_         #I,X3+#]3?#AI#;^7E\XL,=TV^^L
MC[AO]/G!1&TE[PN8WI_BT^[XON7GLY9\%E]F/X=?O>-[TB#2-T
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M>?TXO)Z?9'VS[PW7\VTB.VWT=/I0EFQ?TC'HROR*;7"
M
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M9E9+0^/M*1TZ3W!/#S>'TY$7[I$Y?I,?%7?!6YEWX>WX2Y$+("*I(_T
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M
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MT6.QEN;5ZYK3/)I3&[HB)96#V?P.$N1=M6]*H\]4[^F92"-*W(
M                $*N,76;*\-M>*:4:6K,[5/5RJ]S[3/3KM/14CGMB?-&[
MXCY'.Y&O7X*<[]T5J*2O9?*[5^JO$XCYJUQSYY_#?IR\4<J+;39I=L4T8?#_
M #MWBCS1^//R<<\C0*V[27@CN>"V2Z:9W;6/5K-*-U;-E<21U$Z5?:)&Z&@A
MF:YS-WKZ*L3M'?&5>Y-SP\7M#3<JINQ:LT3IP=T:?Q3'_P"--P,+L_5;IJM3
M=O5QKPM_'_#$_P#ZV;6<=V,T3(X=3="M6,1QJYR)237&Z6YLE,JO15Y7QS]B
MCTV3=43==M]D4U].Q]VKYC$6ZJHX](GC]6K/JVNMT_/V+E-,\\<7KT8GKMP_
MVJP6:@XH^%BI9C%\LE)'D53;;+NRWW2UO8V=\\%.FS6>]>D^)$Y)&;IR\_PL
MK)\ZJN5SE^8^-3/BZSOIJW:3/3NG?$\NC'S?)J;=$9AE_BU1XVD;JJ=^L1T;
MXW3')JFOH;JK;]:-,,7U!H8XZ6:[0+'>;<Q=_-:^!>SJ8>O7E1Z;LWZJQ6KX
MD3S?+JLOQ-5F>3=//$[I_/*E64YA3C\-3>CEW^:>6/SR-MFM;$      !YUW
MNUOL-INE\N]5'0VJRTDU=<ZV3X$-/3L6661WL:UJJ<[5NJY5%%.^9TCIEPN7
M*;=,UU;HC6>B',7K+J5<=7=3,NU N7.SW>K7.MU([_J]%%[U20>KT(FM1=N]
M=U\2_P#*\!3@<-19IY(X_//+/:H3-,=5C<37>GEGLCDCL:P-@P
M ^JAHJNY5M);J""2JKJ^:.FHZ6--WR2RN1C&-3UJJ['&NJ*(FJ=T.5-,U3$1
MOETR: :3T>BVE.+8) D3KA1P>=9'6,_ZQ<ZG9]2_?Q1'>@W[1K2@\ZS*<PQ5
M=[DY/-3&[X]*]\FRZ,!A:;/+R^>J=_YYFYC5MH        59^4TP!]9CFGVI
ME)#NZR5D]@O+TZN[&L;V]*Y?4UCXI$^=Z%A[ XW@W+EB>6.%'5Q3WQV*_P!O
M,'PK=N_')/!GKXX[I[5.Y9ZL@      $K.&NPI_Z0Y/*SKZ%MHI/Q2S_ /\
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MH+M;JE.:GKZ.9D\,B>MLD:JU?H4TURW5;G@U1I/G;BBY3<CA4SK'F?><',
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MQLOGE'J-+SMMB>#\^,LD])'*ZF?OR)\79:N9>OBBKZB<4SX/9R>#]:YQ]O\
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M";[$99X?$S?J\FWN]*?A''V(5MKF7@,-%BGRKF_T8^,\7:H[+;5.
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M:.)FS4_&NZJJE[X# V\%9ILV]T>OGF?/*C<?CKF-O57KF^?5YH\T,",QA@
M       !<IY,C#W4>%ZCYU-%LM_NU-9Z)[N_L[;"LTBM]CG5:)\[?85;M_BN
M%>M6>:)G[TZ>Y9^P6&X-FY>YYT[/_P!6@%?I\
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M[(Y9\LQL55>3;\:>GZL=O'U(QM9F7R3!S3'E5^+'1]:>SBZW/J72ID
M     $]?)_:.-U U9?G%WI5EQS3%L=?'SM]"6[2JJ43/\5RNFZ=RM9OWD.VT
MS3Y+A/!4^5<XOY>7MW=J8;&Y9\IQ7A:O)M\?\W)V;^Q>^4\MT
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M9_)**VEQ?RG,+M7)$\&/Y>+\5X[-X7Y-E]JGEF.%][C_  20-$W@
M                           !!SRAGV.-R^_UJ_..);L3](QZ,HGMI]'S
MZ4*#BY5/)\>3B^R"K/P2N7Y^D(;MU]'QZ<=TICL/^WSZ$]\+W"GUN
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MW<C=^YK6IX%!YYCJL9C+ER=VND>C'%'YYU\9)@8P>#MVXWZ:STSQRW>:EM0
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M5TF\+VD,>BVCF,8M/3MAR*NC]U\P?TYG7*K:UTC'*G?V+4;"GL9N41M!F?\
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MIJ>"CIX*2EB9!34L;8J>!B;-8QB<K6HGJ1$//-54U3K+T#3$4QI#]SX^@
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M';K]!"=NL;X+!Q:C?7/JIXY]>B:;$8/PN+F[.ZB/75Q=VJ\HJ-;(
M                             @YY0S['&Y??ZU?G'$MV)^D8]&43VT^C
MY]*%!Q<JGD^/)Q?9!5GX)7+\_2$-VZ^CX]..Z4QV'_;Y]">^%[A3ZW
M &N]7?VI]3_P2O7Z#,9N6?M5KTZ?:AA9E^RW?0J]F7+>>A7G]-SR?,$<W$E9
M)'INZELMVEA7U.6#L_\ Y7J1/;6=,NJ]*GO2O8R-<QIZ)[E_!3*X@   K8\I
MK^U/@/X6I^@U).]@?VJYZ']T(-MY^RV_3_ME2D6NJM=;Y,K]J?/OPM7]!IBJ
M-OOVJWZ']TK4V#_9;GI_VPLG((G(  YVN-^X27'B>U-<[=&4<ELI(6+X-AME
M*U?QNW7Z2[]DJ.#EEKK]J5*;5U\+,KO5[,(H$C1UO>T<3FOM@M-KL5GU2RBW
MVBRTD-!:J"*1B,@IJ9B111M]#N:QJ(AI[NS^ N5375:IF9G6>F6WMY]CK=,4
M4W:HB(TCHAZ/]5EQ'?PO9;_G(_\ <.'Z-Y=^YI<_TBS#]]4?U67$=_"]EO\
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M61F/TK62;>DC756ZHB^WE3\1 /\ 4"?U%KTI[D]V"C]?=]&.]<T58M
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M2ROTBS#]]4?U67$=_"]EO^<C_P!P?HWEW[FD_2+,/WU1_59<1W\+V6_YR/\
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MJ(7*G>G/&JINGBG>GB0Z_A[EBK@7*9IJYIXDPL7[=^GAVZHJCGCC>Z=+M
M        !2?Y1[5CZH]0;)I5;*GGM>!0)67QC%]%]UKF(YK7>"]C3JW;U+(]
M"U]A<M\%AZL15OKXH]&/C/="J]N,Q\+?IP].ZCCGTI^$=\JVR=H,
M   #HOX/M'5T<T6L%ON-'YKEF4_].Y9S)M(R>I:G8TSM^J=A#RL5.[GYU3O*
M.VGS3Y?C:IIGQ*?%IZM\]<^K1=NS66?(<'3$QX]7C5=>Z.J/7JE*1Y(
M          "'_&!PVT^O&$>Z%B@@BU)Q*-\V-52[-\\A^%+;Y7>I_?&J_!?X
MHUSR3[,9[.6WM*_FJM_F_B^/FZD:VER.,QLZT?.4[O/_  _#S];GSJZ6IH:J
MIH:VGFI*RCE?!5TLS59)%+&O*]CVKU16JFRHI=5-451K&Y3%5,TSI.]\Y]?
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MV=JG^$*9VSQWRC'S1&ZW'!Z]\_#J7%L=@?D^!BN=]<\+JW1\>M-PB:5@
M                                "#GE#/L<;E]_K5^<<2W8GZ1CT91/
M;3Z/GTH4'%RJ>3X\G%]D%6?@E<OS](0W;KZ/CTX[I3'8?]OGT)[X7N%/K<
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M0T6T&U%.:6(M1;X.E7"WZ\DQS1SMYD&S%65WYNS<X6M.F[3EB>?S)Y$.2\
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M*IJJWS.L],K^MVXMTQ33NCB['H'!S
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MD>3/VHYO2[^G?5>U>SGR:9Q-B/$GRH^S//Z/=T*VB=H,
M       +5_)JZ2NJ;EE6LUTIE["W,=C^)N>G1T\J-DK9F_<,Y(T7N]-Z=Z%=
M;>9EI31A:>7QJO='OZH6'L+EVM5>*JY/%I]\^[KE;Z5DLH
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MU>?YW*OB7CLI;HHRVUP>76>O6=?@I+:FY77F-WA<FD=6D:?%%DD*/@
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MWV* S+'58W$5WJOK3V1R1U0OO+L%3@L/19I^K';/+/7+8Q@LT
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M ?UY7/M[9G:>,?'@;W%=C^O\>>.N/-4FTNS4X&?#6>.U/]'X<T]4^> Y,D/
M                   M?\G/H.^:IKM=\DHE2"F[:V:?1RM^'(N\=;7-W\&I
MO Q?6LOR4*XVYSC2(P=$^>OW4^^>I8NQ.4:S.+KCS4>^KW=JW4K19
M                                 (.>4,^QQN7W^M7YQQ+=B?I&/1E$
M]M/H^?2A0<7*IY/CR<7V059^"5R_/TA#=NOH^/3CNE,=A_V^?0GOA>X4^MP
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MJJ1[8O$W<7CKUZY.M4T\?;"0[98:UA<#9LVXTB*O=*H4LQ6KH?X%_L6-+O\
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M&_B7=J]44OK+<PMX^Q3>M[I]4\L2HK,<!<P-^JS<WQZXY)AK<SF"
M;(TATZN&K.I6'Z?6Y9(Y,DN#(:RJ8B*M/2,WEJY]EZ>]0L>[;QVV,',\=3@L
M-7>GZL=L\D=<L[+<%5C<119CZT]D<L]4.GFS6BW8_:+78;12QT5JLM)#0VRC
MCZ-B@IV)'&Q/F:U$//UV[5=KFNK?,ZSTRORU;IMT113NB-(ZGIG!S
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M2B;]^N_7-RN=:IG65Y6+-%FB+=$:4QQ0]HZG:
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MU6ZFI)')]N^)C7.^E37XC'8C$?.W*JNF9EL,/@</A_FJ*:>B(AFIBLH
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M761K%+&Y/6U?!>]%3HJ=4Z%IV+]N_1%=N=:9Y85??L5V*YHN1I5')+Q#M=0
M            #,<!P/*-3,LL^%X?;9;I?;U,D5/$W?DC;\>:9R(O)'&GI.<O
M<AC8S&6L):F[=G2F/SI'G9.#P=S%W8M6HUJG\ZSYG1=P^:%8YH%@5+BMH5E?
M>:SEJLLR)6<LE=6<NRKZTBC^#&WP3[97*M&YUG%S,[_A*N*/JQS1\>==V391
M;RVQX.GCGZT\\_#F;U-0VP
M
M          <E9Z2><DGN#+[)O2?^/U?Z!4D?VI^C+W1'M0W^R_TE:Z9]F71L
M4:NX
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MW4\WGGGG\PN/),CLY9;TIXZYWU<_FCFA(XT;=@
M
M                           Y*STD\Y)/<&7V3>D_\?J_T"I(_M3]&7NB
M/:AO]E_I*UTS[,NC8HU=P
M                                                        *L^-
MWA"=?FW+672VU.DOK-Y\YQ2DC3]F,1%5]PIF-ZK,G[JQ/KGPT]-%Y[#V3VF\
M'IA<1/B_5JGD_AGS<W-NW;J_VKV:\)KBL/'C?6IY_P"*//S\^_?OIW+/5D
M  "R'R<>DOU3:AWK5.Z4B26G (/-;(^1/1?=JUBMYF[ILO80<RKZE>Q2"[<Y
MEX+#TX>G?7O]&/C/=*<;$9=X7$3B*HXJ-WI3\([X79E3K5
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M[-.D?G?SLX,1E@
M
M    <E9Z2><DGN#+[)O2?^/U?Z!4D?VI^C+W1'M0W^R_TE:Z9]F71L4:NX
M
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M:+ZY%C:BO7VNW4C&)QE[$SPKM<U3YYU2;#82SAHX-JB*8\T:,L,9D
M
M
M
M                            JBXR^"Y]>^YZMZ.V=SZ]ZNJ<RP:BCW6=
M5ZOK:")OQ_&2)OPOA-]+='6-LMM5P=,-BIXOJU3R>:KW3VJ[VGV6X6N)PT<?
MUJ8[Z??'8J)5%1514V5.]"S%;/\  )><$FE'ZJ&NEAFKJ99L=P1$R.]*J>@Y
M],]/,X57N].H5JJGBUKB,[69C\CP-6GE5^+'7OGL]>B2[*9=\KQM.ODT>-/5
MN]?O=#!2:Z
M
M
M
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MZOJ_'K3G(@EH
M
M
M
M                                 C=K/PIZ/ZY5<-VRNTUMJR.+D23)
M[')'25L\;.B1SJ^.6.5-DV17L5R)T:Y#>Y5M'C,NC@VYUIYJN..K=IVM'FFS
MV$S&>%<C2KGIXIZ]^J0]#14EMHJ2W4$$=+0T$,=-1TL:;,CBB:C&,:GJ1$V-
M)75-<S,[Y;JFF*8B(W0^HXN0
M
M
M
M
M
M
M
M
M
M
M
M
5                        ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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ML9H>F+TN6/;/ZM"K/O\%4$L#!!0    ( ",X=U"ZH3F*UP$  #(&   -
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ (SAW4!AEQ@/M    *P(  !$
M             ( !F0$  &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M(SAW4)E<G",0!@  G"<  !,              ( !M0(  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  C.'=04[A14: "  "8"P  &
M    @ 'V"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M(SAW4$['DY9. @  VP4  !0              ( !S L  'AL+W-H87)E9%-T
M<FEN9W,N>&UL4$L! A0#%     @ (SAW4+JA.8K7 0  ,@8   T
M     ( !3 X  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  C.'=0+6VE:#H!
M   G @  #P              @ %.$   >&PO=V]R:V)O;VLN>&UL4$L! A0#
M%     @ (SAW4/_ )@B]    A0(  !H              ( !M1$  'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ (SAW4 N/V ,A 0
M5P0  !,              ( !JA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
2      H "@"  @  _!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>fold-20200323_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="fold-20200323.xsd" xlink:type="simple"/>
    <context id="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178879</identifier>
        </entity>
        <period>
            <startDate>2020-03-02</startDate>
            <endDate>2020-03-02</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF80L2ZyYWc6OWM1YzQwOGI0Y2ViNDA5ODhkODgxMTdmMzZlYzVjYWIvdGFibGU6NmRlMmFlNzFlNGJjNGZjZjk3YmYzZDY4ZjYwMTExODUvdGFibGVyYW5nZTo2ZGUyYWU3MWU0YmM0ZmNmOTdiZjNkNjhmNjAxMTE4NV8xLTEtMS0xLTA_e55cb187-f279-4102-97b4-2efc8f94f429">0001178879</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF80L2ZyYWc6OWM1YzQwOGI0Y2ViNDA5ODhkODgxMTdmMzZlYzVjYWIvdGFibGU6NmRlMmFlNzFlNGJjNGZjZjk3YmYzZDY4ZjYwMTExODUvdGFibGVyYW5nZTo2ZGUyYWU3MWU0YmM0ZmNmOTdiZjNkNjhmNjAxMTE4NV8yLTEtMS0xLTA_d652aa0f-5db7-4843-b366-51e0d2b0301f">false</dei:AmendmentFlag>
    <dei:WrittenCommunications
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF80L2ZyYWc6OWM1YzQwOGI0Y2ViNDA5ODhkODgxMTdmMzZlYzVjYWIvdGFibGU6NmRlMmFlNzFlNGJjNGZjZjk3YmYzZDY4ZjYwMTExODUvdGFibGVyYW5nZTo2ZGUyYWU3MWU0YmM0ZmNmOTdiZjNkNjhmNjAxMTE4NV8zLTEtMS0xLTA_c3483061-77d2-4b83-8aaf-daf0271d6071">false</dei:WrittenCommunications>
    <dei:DocumentType
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM0_35dc0c17-ab4f-433d-aeee-c0b3eae25ff8">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18yMjY_78812f4d-1233-4e55-9b86-6f514b0f5f81">2020-03-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzQx_c7a6bba3-f5e1-4aaa-9cf0-c56d3dcef041">AMICUS THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM1_e7361dde-8b46-4841-8750-28db53db258a">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6OTQ2MjMzYWNiYTRkNDU5NjgxZTliYmRjOTUwOTI2OGYvdGFibGVyYW5nZTo5NDYyMzNhY2JhNGQ0NTk2ODFlOWJiZGM5NTA5MjY4Zl8wLTItMS0xLTA_d4fcaabc-606f-447a-b846-516b6366b692">001-33497</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6OTQ2MjMzYWNiYTRkNDU5NjgxZTliYmRjOTUwOTI2OGYvdGFibGVyYW5nZTo5NDYyMzNhY2JhNGQ0NTk2ODFlOWJiZGM5NTA5MjY4Zl8wLTQtMS0xLTA_5d9fb3e9-895a-4164-b10b-c6a8f8b6ba9f">71-0869350</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMw_f67dd951-542a-45ff-95ff-d5b75529db12">1 Cedar Brook Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzQy_99ef1f62-08c2-476e-95b6-02a4d77d4c94">Cranbury</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM2_32b89240-65d4-489c-8d17-54c75bcdcbd5">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMx_5a9667c1-6556-42a0-af99-cc77e82d22d5">08512</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM3_abbc9281-0c14-4620-944b-0e77eab1160d">609</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM4_033be30d-d574-470c-be85-2aaad502f94a">662-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y183Nzc_c3483061-77d2-4b83-8aaf-daf0271d6071">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzM5_8d09c0c8-97d2-494d-834b-da9170d70d77">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMy_78b2155b-0052-4571-95a4-bd5345c71675">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzQw_f784ed87-cade-4e99-8ceb-df5f2b52c31b">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6YTZmZTRmZWM1ZThiNGQ5OWI4MGFmYzE2MzY1ODVhNzMvdGFibGVyYW5nZTphNmZlNGZlYzVlOGI0ZDk5YjgwYWZjMTYzNjU4NWE3M18xLTAtMS0xLTA_06baecc4-56f8-494d-8c14-b3a32a0a7b7b">Common Stock Par Value $0.01</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6YTZmZTRmZWM1ZThiNGQ5OWI4MGFmYzE2MzY1ODVhNzMvdGFibGVyYW5nZTphNmZlNGZlYzVlOGI0ZDk5YjgwYWZjMTYzNjU4NWE3M18xLTEtMS0xLTA_72d10484-e9c2-40be-90b5-2458138fdbd5">FOLD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGFibGU6YTZmZTRmZWM1ZThiNGQ5OWI4MGFmYzE2MzY1ODVhNzMvdGFibGVyYW5nZTphNmZlNGZlYzVlOGI0ZDk5YjgwYWZjMTYzNjU4NWE3M18xLTItMS0xLTA_cafa2d9f-2edc-4956-827d-9268e50dd325">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302"
      id="id3VybDovL2RvY3MudjEvZG9jOmVjMTA2NWI3OWU0NTQ1MTM5NDQxZTVkZGZkMGY2OGQwL3NlYzplYzEwNjViNzllNDU0NTEzOTQ0MWU1ZGRmZDBmNjhkMF8xL2ZyYWc6NjdmYTQ0ODNmOGRiNDY0ODlhZGZjYzJjY2RiNmM1NWMvdGV4dHJlZ2lvbjo2N2ZhNDQ4M2Y4ZGI0NjQ4OWFkZmNjMmNjZGI2YzU1Y18xNzMz_3f21207b-0c8d-40e0-b8b4-17eb81daa9f8">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "fold-20200323.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "fold-20200323_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "fold-20200323_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "fold-20200323.htm"
     ]
    },
    "labelLink": {
     "local": [
      "fold-20200323_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "fold-20200323_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "fold-20200323.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2019-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 95,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "fold",
   "nsuri": "http://www.amicustherapeutics.com/20200323",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fold-20200323.htm",
      "contextRef": "i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.amicustherapeutics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "fold-20200323.htm",
      "contextRef": "i1e868c7e85904052ae1949a50f0f14b6_D20200302-20200302",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover page.",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.amicustherapeutics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001178879-20-000017-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001178879-20-000017-xbrl.zip
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MG\+O5ES0&N$1D>)[Z0D>1!+V@$2\FC )O(F8X)4H !%*1IA5C+ '#*UZI7_
M P%V)!,JBT6'W@,+GVJ>& 17.758*4@+T$J81T++08V K0U@NA&7&@%8L!%^
M3'CJV>3H\)3]K**4O>VQD5:S&.8V@ZT5QG)@M2:"IV +!=>P1,=#< *)$# Y
M+:9Y3%>N)8?_H5"P,^E$: % P]W@QI <*.?H<2(A1DT[!BBIF028!O -H%")
M55D,J$VWE%N%&_0'F/)38>;TNCUI83+!UU#O::XKF==>'M,KL5$:(AIID9$
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MND-5I<N^Q:C+%2'3S_AZP;M!7P;L7*X]+ACNPX1"U )AKUVMBEO,N&!YV<K
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M9'J-G4^<>)A_AJK/YH\2*YJ3\:8<-JS'DV"PU^DBBO-LT<UXTF1^/YI&_SQ
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MO5&ZSEQ=A@,(@SGB"15'@3\Y@7]Q$_&2';(%_!DF8W_W_P%02P,$%     @
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M(YI0)W_QFDQ>.^&LX^?.#WY8[*<23NRS3<%L81 @G-J6O/D%N]4?4$L#!!0
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MZ?')F9X4+YFH(9F64X$LWXP]$_MC?];6W,"N I\K<3[)?H[,N88 1,L/H/P
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MK;D6P;L)SA9H'\75[ TG.5L8-<U9!W3M5"]5:@Q-/Z12/?Q7/8YQ&)<WC!E
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MD0Z8>/MH(([1QOW&YC ,)MP*?;: +QSX[J9*>;:NJ[L2R["0YTXIW,BZ-FX
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M9"TR,#(P,#,R,RYH=&U02P$"% ,4    "  C.'=0O#Z9@:H"   O"@  $0
M            @ &.*P  9F]L9"TR,#(P,#,R,RYX<V102P$"% ,4    "  C
M.'=042P^F(H!  #F @  %0              @ %G+@  9F]L9"TR,#(P,#,R
M,U]C86PN>&UL4$L! A0#%     @ (SAW4'FLCU<H @  J@8  !4
M     ( !)#   &9O;&0M,C R,# S,C-?9&5F+GAM;%!+ 0(4 Q0    ( ",X
M=U!9:J8G@PH  ,5>   5              "  7\R  !F;VQD+3(P,C P,S(S
M7VQA8BYX;6Q02P$"% ,4    "  C.'=0"94)1[L&  "&,0  %0
M    @ $U/0  9F]L9"TR,#(P,#,R,U]P<F4N>&UL4$L%!@     '  < Q $
' "-$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.1</span><table class="report" border="0" cellspacing="2" id="idp6635083776">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Mar. 02, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover page.</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 23,  2020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMICUS THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">71-0869350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1 Cedar Brook Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cranbury<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">662-2000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock Par Value $0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FOLD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>95</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="fold-20200323.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amicustherapeutics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="fold-20200323.htm">fold-20200323.htm</File>
    <File>ex991org.htm</File>
    <File>fold-20200323.xsd</File>
    <File>fold-20200323_cal.xml</File>
    <File>fold-20200323_def.xml</File>
    <File>fold-20200323_lab.xml</File>
    <File>fold-20200323_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
